The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma
- 1 October 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (1) , 283-286
- https://doi.org/10.1111/j.1365-2141.2000.02310.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ibandronate Reduces Osteolytic Lesions but not Tumor Burden in a Murine Model of Myeloma Bone DiseaseBlood, 1999
- Anti‐myeloma activity of pamidronate in vivoBritish Journal of Haematology, 1998
- Bisphosphonates as Anticancer DrugsNew England Journal of Medicine, 1998
- Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.Journal of Clinical Oncology, 1998
- In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonatesLeukemia, 1998
- Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activityBritish Journal of Haematology, 1997
- Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouseBritish Journal of Cancer, 1997
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myelomaCancer, 1985
- Cell Death: The Significance of ApoptosisPublished by Elsevier ,1980